Fort LP’s Ionis Pharmaceuticals IONS Stock Holding History

Fort LP’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,847	Closed	-$218K	–	255
2020 Q4	$218K	Sell	3,847 -980	-20%	-$48.8K	0.07%	255
2020 Q3	$229K	Buy	+4,827	New	+$268K	0.1%	282

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fort LP's IONS Position: Q1 2021 in Review

Fort LP sold out of Ionis Pharmaceuticals (IONS) in Q1 2021, closing a stake of 3,847 shares — an estimated $218K sold.

Fort LP first reported a position in IONS in Q3 2020 and held it in 2 quarters. The position peaked at $229K in Q3 2020. 364 funds tracked by Wall St. Rank hold IONS as of Q1 2021.

Fort LP reported no remaining Ionis Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Fort LP sold 3,847 Ionis Pharmaceuticals shares in Q1 2021, an estimated $218K.
Fort LP first reported a position in Ionis Pharmaceuticals in Q3 2020 and held it in 2 quarters.
Fort LP's Ionis Pharmaceuticals position peaked at $229K in Q3 2020.
364 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2021.

Based on Fort LP's 13F filing for Q1 2021, filed 14 May 2021.